[Explanation] Hainan Free Trade Port Boao Lecheng International Medical Tourism Pilot Zone's first special-approved off-the-shelf drug and gastrointestinal stromal tumor clinical emergency drug project kick-off meeting was held in Haikou on July 28. It was announced at the meeting that the innovative drug reptinib, which was approved for marketing in the United States in May 2020, officially landed in the Lecheng Pilot Zone. The drug will become the first imported licensed drug to be used "out of the park".

　　[Explanation] In March 2020, the "Interim Measures for the Administration of the Use of Imported Drugs Urgently Needed for Clinical Use in the Hainan Boao Lecheng International Medical Tourism Pioneer Zone" was released, allowing patients to take away a small amount of oral clinically needed imported drugs for personal use only. District use.

　　[Explanation] Gu Gang, director of the Boao Lecheng Pioneer Zone Administration Bureau, said that as the only "medical special zone" in China, Lecheng Pioneer District has benefited from the Hainan Free Trade Port's new policy, allowing the latest internationally listed and domestically unapproved innovative drugs Speed ​​up the listing in Lecheng Pioneer District and serve domestic patients. Now that patients can take imported licensed drugs out of the park, it is also a major breakthrough.

　　[Concurrent] (Gu Gang, Director of the Administration Bureau of Boao Lecheng Pioneer District) (this project) embodies that the policy of (patients) taking medicine out of the park has been officially implemented. Today's reptinib is used to diagnose and treat patients. This patient can take the medicine out of the park. This is also a very important policy breakthrough.

　　[Explanation] According to reports, the drug is an innovative drug for the treatment of fourth-line gastrointestinal stromal tumors, which has changed the plight of no drugs available for patients after the advancement of third-line treatment. It is estimated that 30,000 people will get sick every year in China. After the introduction of this new policy, it has effectively solved the problem that patients must be hospitalized every time they use clinically urgently needed imported drugs, greatly reducing the cost of medication, and making the diagnosis and treatment of patients at home and abroad more convenient.

　　[Explanation] The reporter learned from Boao Super Hospital that at present, patients have applied for medication of reptinib and applied to take the medicine out of the park for use. This also marks that the drug will become the first special approval to be used in Lecheng pilot area. Medicine is urgently needed in clinic.

　　[Concurrent] (Patient Mr. Huang) I heard from the doctor, or from various aspects (information) that this (using imported licensed drugs) should be hard-won. For one thing, it may depend on the country's policy in Hainan. Secondly, I might be lucky. If I can come here from a foreign country, I will be able to try it right away, which is relatively lucky.

　　[Explanation] Since its establishment in 2013, the Boao Lecheng International Medical Tourism Pilot Zone has adopted the “first pilot” policy to build a regional medical highland, gathering a batch of global innovative medical devices. Currently, the number of imported licensed medical devices has exceeded 100 cases. There are over 100 new tumor drugs and rare disease drugs.

　　Reporter Zhang Qianyi Lin Shijie Comprehensive Report from Hainan

Editor in charge: [Yu Xiao]